| Title: |
Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines |
| Authors: |
Sally F. Gordon; Elise Virah Sawmy; Eleanor Duckworth; Michelle Wolthuizen; Hazel J. Clothier; Malinda Chea; Naveen Tenneti; Ngaree Blow; Jim P. Buttery; Joseph de Luca; Tony M. Korman; Sara Barnes; Charlotte Slade; Callum Maggs; Michelle L. Giles; Benjamin W. Teh; Craig Aboltins; Katherine M. Langan; Annaliese Van Diemen; Nigel W. Crawford |
| Source: |
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022) |
| Publisher Information: |
Taylor & Francis Group, 2022. |
| Publication Year: |
2022 |
| Collection: |
LCC:Immunologic diseases. Allergy; LCC:Therapeutics. Pharmacology |
| Subject Terms: |
covid-19; vaccines; vaccination; vaccine allergy; immunisation service; Immunologic diseases. Allergy; RC581-607; Therapeutics. Pharmacology; RM1-950 |
| Description: |
The Victorian Specialist Immunization Services (VicSIS) was established in Victoria, Australia, in February 2021, aiming to enhance vaccine safety services for Coronavirus disease (COVID-19) vaccines. VicSIS supports practitioners and patients with complex vaccine safety questions, including those who experience adverse events following immunization (AEFI) after COVID-19 vaccines. VicSIS provides individual vaccination recommendations, allergy testing, vaccine challenges, and vaccination under supervision. VicSIS initially comprised of eight adult COVID-19 specialist vaccination clinics, subsequently, expanding to better support pediatric patients as the Australian vaccine roll-out extended to adolescents and children. Since their establishment to September 2021, the inaugural VicSIS clinics received a total of 26,401 referrals and reviewed 6,079 patients. Consults were initially predominantly for pre-vaccination reviews, later predominantly becoming post-vaccination AEFI reviews as the program progressed. Regardless of the type of consult, the most common consult outcome was a recommendation for routine vaccination (73% and 55% of consult outcomes respectively). VicSIS is an integral component of the COVID-19 vaccination program and supports confidence in COVID-19 vaccine safety by providing consistent advice across the state. VicSIS aims to strengthen the health system through the pandemic, bolstering specialist immunization services beyond COVID-19 vaccines, including training the next generation of vaccinology experts. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2164-5515; 2164-554X |
| Relation: |
https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X |
| DOI: |
10.1080/21645515.2022.2052701 |
| Access URL: |
https://doaj.org/article/3cc45d2f2e124f7ea32ce507b220a062 |
| Accession Number: |
edsdoj.3cc45d2f2e124f7ea32ce507b220a062 |
| Database: |
Directory of Open Access Journals |